Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. LifeMD, Inc.
  6. News
  7. Summary
    LFMD   US53216B1044

LIFEMD, INC.

(LFMD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

LIFEMD, INC. : Other Events (form 8-K)

07/15/2021 | 04:34pm EDT

Item 8.01 Other Events.

On July 15, 2021, LifeMD, Inc. (the "Company") issued a press release announcing its collaboration with the world's leading provider of laboratory diagnostic services and a technology leader in in-home healthcare to deliver telehealth access to diagnostic laboratory testing services. Specifically, the Company, on behalf of its customers, has engaged Quest Diagnostics Incorporated ("Quest Diagnostics") as the Company's laboratory services provider to perform certain clinical laboratory diagnostic services based on orders submitted to Quest Diagnostics by licensed health care providers who are under contract with the Company and are authorized under U.S. federal or state law to order laboratory tests. Patients of LifeMD's affiliated providers gain access to more than 150 of the most ordered laboratory tests at substantially discounted prices, and which can be completed in the comfort, safety, and convenience of their home or office. In addition, the Company has engaged Axle Health Inc. ("Axle Health") to assist the Company in establishing a platform to enable patients of the Company's medical practice clients ("MP Clients") to schedule certain nursing services, including blood draws, injections, and other basic healthcare services, and to furnish operational support services to medical practices using the platform. In connection therewith, Axle Health granted the Company a revocable, nontransferable, non-exclusive right and license, with the right to grant sublicenses, to install and use the software and other technology relating to the platform developed, owned, or with the right to grant sublicenses to install and use the software and/or other technology developed, owned, or licensed by Axle Health, including the platform, to facilitate the scheduling and provision of certain nursing services to patients of MP Clients. A copy of the press release is filed hereto as Exhibit 99.1 and is incorporated herein by reference.




Item 9.01. Exhibits.



(d) Exhibits



Exhibit No.   Exhibit
99.1            Press Release, dated July 15, 2021

© Edgar Online, source Glimpses

All news about LIFEMD, INC.
09/22LIFEMD, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
09/21LIFEMD : to Present at the Cantor Fitzgerald Virtual Global Healthcare Conference
AQ
09/20LIFEMD, INC.(NASDAQCM : LFMD) added to S&P Global BMI Index
CI
09/15INSIDER BUY : LifeMD
MT
09/13LIFEMD : Industry veteran brings deep financial and management expertise to LifeMD as comp..
PU
09/13LIFEMD, INC. : Change in Directors or Principal Officers, Other Events (form 8-K)
AQ
09/13LIFEMD : Appoints Seasoned Investor Naveen Bhatia to Board of Directors
AQ
09/13LifeMD, Inc. Appoints Naveen Bhatia to its Board of Directors
CI
09/08LIFEMD : to Present at the H.C. Wainwright Annual Global Investment Conference
AQ
08/30LIFEMD : to Adopt Prescryptive Health Digital Pharmacy, Prescriptions Platform for Telehea..
MT
More news
Analyst Recommendations on LIFEMD, INC.
More recommendations
Financials (USD)
Sales 2021 97,8 M - -
Net income 2021 -57,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 -3,22x
Yield 2021 -
Capitalization 183 M 183 M -
Capi. / Sales 2021 1,87x
Capi. / Sales 2022 1,26x
Nbr of Employees 56
Free-Float 66,8%
Chart LIFEMD, INC.
Duration : Period :
LifeMD, Inc. Technical Analysis Chart | LFMD | US53216B1044 | MarketScreener
Technical analysis trends LIFEMD, INC.
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 1
Last Close Price 6,89 $
Average target price 30,00 $
Spread / Average Target 335%
EPS Revisions
Managers and Directors
Justin Schreiber Chairman & Chief Executive Officer
Alexander Mironov President
Marc Benathen Chief Financial Officer
Joseph V. DiTrolio Independent Director & Chief Medical Officer-US
Stefan Galluppi Director & Chief Technology Officer
Sector and Competitors
1st jan.Capi. (M$)
LIFEMD, INC.5.51%183
AMAZON.COM, INC.4.88%1 734 822
JD.COM, INC.-15.84%114 829
WAYFAIR INC.21.60%28 530
ETSY, INC.25.26%28 208
ALLEGRO.EU SA-29.59%15 534